Coeptis Therapeutics Azioni (NASDAQ: COEP)

Ultime notizie per Coeptis Therapeutics (NASDAQ:COEP) Azioni

Coeptis Therapeutics

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Barclays analyst Andrew Lazar maintains Oatly Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLY#NASDAQ">OTLY</a>) with a Overweight and raises the price target from $11 to $14.

News

Price Target

Analyst Ratings

OTLY

Barclays Maintains Overweight on Oatly Group, Raises Price Target to $14

WIIM

ORCL

Oracle shares are trading higher after the company announced $3 billion in AI and cloud infrastructure investments.

Barclays analyst Lauren Lieberman maintains ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) with a Equal-Weight and raises the price target from $60 to $73.

Barclays Maintains Equal-Weight on ODDITY Tech, Raises Price Target to $73

Shares of USA Rare Earth Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAR#NASDAQ">USAR</a>) are climbing sharply Tuesday afternoon, riding a wave of positive sentiment sweeping through the domestic critical minerals sector for the session.
The stock is rallying in sympathy with competitor MP Materials Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>), which saw its shares soar following two significant developments boosting the case for American rare earth production.
What To Know: MP Materials announced a landmark <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46414833/mp-materials-stock-surges-on-500-million-partnership-with-apple">long-term partnership</a> to supply Apple Inc with rare earth magnets manufactured in the U.S. from 100% recycled materials. 
Under the agreement, MP will process recycled feedstock at its Mountain Pass, California facility and produce the finished magnets for the iPhone maker at its plant in Texas. This major corporate endorsement highlights the growing demand for a secure, domestic supply chain.
Adding to the bullish sentiment, a CNBC <a href="https://www.cnbc.com/2025/07/15/us-pentagon-defense-department-rare-earth-critical-mineral-mp-materials.html">report</a> revealed the Pentagon is taking direct action to counter China's dominance. A defense official confirmed the Department of Defense recently acquired a major equity stake in MP Materials, signaling robust government backing for American producers. 
Per the CNBC report, The Pentagon has invested over $540 million to support the critical mineral supply chain, viewing it as essential for national security.
This combination of a landmark commercial deal and government investment in a U.S.-based peer has ignited investor confidence across the industry, lifting related stocks like USAR on expectations of a potentially revitalized domestic rare earth ecosystem.
Benzinga Edge Rankings: According to recent data from <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a>, Wall Street has shown increasing interest in USA Rare Earth. Within the last two months, two separate analyst firms have initiated coverage on the stock, both with positive outlooks. 
On May 29, Roth Capital began its coverage with a Buy rating and a $15 price target. This was followed on June 13 by Canaccord Genuity, which also initiated coverage with a Buy rating and a higher price target of $17.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, USAR shares are trading higher by 32% to $15.64 Tuesday afternoon. The stock has a 52-week high of $20.00 and a 52-week low of $5.56.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46422009/rare-earth-royalty-meet-the-power-players-shaping-the-industry">Rare Earth Royalty: Meet The Power Players Shaping The Industry</a>
<h2 class="wp-block-heading">How To Buy USAR Stock</h2>
By now you're likely curious about how to participate in the market for USA Rare Earth &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

USAR

Why USA Rare Earth (USAR) Stock Is Skyrocketing Today

Citigroup shares are trading higher after the company reported better-than-expected Q2 financial results.

Taiwan Semiconductor shares are trading higher amid strength in chip stocks as the US eases chip export curbs.

Barclays analyst Lauren Lieberman maintains Olaplex Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLPX#NASDAQ">OLPX</a>) with a Equal-Weight and raises the price target from $1.4 to $1.5.

OLPX

Barclays Maintains Equal-Weight on Olaplex Hldgs, Raises Price Target to $1.5

<a href="https://www.barrons.com/articles/chinese-biotech-obesity-zepbound-lilly-trial-38914a27" title="https://www.barrons.com/articles/chinese-biotech-obesity-zepbound-lilly-trial-38914a27">https://www.barrons.com/articles/chinese-biotech-obesity-zepbound-lilly-trial-38914a27</a>

Biotech

Global

General

Reported Earlier: "Lilly's Zepbound Faces a Potential Weight-Loss Rival. It's Made by a Chinese Biotech." - Barron's

Cryptocurrency markets are trading lower on Tuesday despite an in-line <a href="https://www.benzinga.com/markets/economic-data/25/07/46413961/june-inflation-cpi-report">consumer price inflation report.</a>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$116,848.09</td>
</tr>
<tr>
<td>Ethereum</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$3,072.94</td>
</tr>
<tr>
<td>Solana</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$162.49</td>
</tr>
<tr>
<td>XRP</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.91</td>
</tr>
<tr>
<td>Dogecoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1950</td>
</tr>
<tr>
<td>Shiba Inu</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001353</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume increasing by 141.1% and daily active addresses growing by 28.3%. Transactions greater than $100,000 are up from 8,732 to 16,402 in a single day. Exchanges netflows are down by 805.3%.</li>
<li>Coinglass data reports 136,584 traders were liquidated in the past 24 hours for $529.10 million.</li>
<li>The top gainers/losers in the past 24 hours include Pump.fun (CRYPTO: PUMP), Pudgy Penguins (CRYPTO: PENGU), and Sei (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SEI</a>).</li>
</ul>
Notable Developments:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46424764/trump-wishes-bitcoin-ethereum-xrp-happy-crypto-week-it-is-all-part-of-make-america-great-again">Trump Wishes Bitcoin, Ethereum, XRP &#8216;Happy Crypto Week!&#8217; — &#8216;It Is All Part Of Make America Great Again&#8217;</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46412500/exclusive-amaze-goes-crypto-forward-launches-blockchain-payment-strategy-with-stablecoin-phase-one">EXCLUSIVE: Amaze Goes Crypto-Forward, Launches Blockchain Payment Strategy With Stablecoin Phase One</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46409456/standard-chartered-enters-crypto-trading-first-big-bank-to-offer-deliverable-btc-eth-to-institutions">Standard Chartered Enters Crypto Trading — First Big Bank To Offer Deliverable BTC, ETH To Institutions</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46422474/polymarket-home-free-as-trump-led-doj-closes-biden-initiated-probes">Polymarket Home Free As Trump-Led DOJ Closes Biden-Initiated Probes</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46412235/i-told-you-so-maxine-waters-predicts-massive-fraud-if-crypto-bills-pass">&#8216;I Told You So&#8217;: Maxine Waters Predicts Massive Fraud If Crypto Bills Pass</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46415503/bitcoin-whale-moves-80000-btc-is-a-9-billion-dump-coming">Bitcoin Whale Moves 80,000 BTC — Is A $9 Billion Dump Coming?</a></li>
</ul>
Trader Notes: Crypto trader Michael van de Poppe says the market is playing out a "classic move," with more downside likely as Bitcoin and Ethereum look poised to flush overleveraged long positions. 
Despite the broader uptrend, he warns that increased volatility could trigger sharp short-term corrections.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Classic move on the markets here. LIkely we&#39;re going to be seeing some more downside on <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> and <a href="https://twitter.com/hashtag/Ethereum?src=hash&amp;ref_src=twsrc%5Etfw">#Ethereum</a> to squeeze out the longs. Remember; volatility goes up, price goes up, this means harsh corrections are around the corner. <a href="https://t.co/RvVjw2PP98">pic.twitter.com/RvVjw2PP98</a>
&mdash; Michaël van de Poppe (@CryptoMichNL) <a href="https://twitter.com/CryptoMichNL/status/1945143820741697846?ref_src=twsrc%5Etfw">July 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Rekt Capital <a href="https://x.com/rektcapital/status/1945135806990921777">highlighted</a> Bitcoin nearing the Daily CME Gap between $114,000–$117,000, a zone that has historically acted as a price magnet. 
Traders are watching this level closely as a likely area for mean reversion before any strong continuation.
Roman Trading is <a href="https://x.com/Roman_Trading/status/1945114592599802342">focused</a> on a possible $112,000 retest. While expecting choppy price action, he suggests there's no urgency in entering — preferring to wait for clean lower timeframe (LTF) confirmations before taking any long setups.
Santiment data <a href="https://x.com/santimentfeed/status/1944965147472064547">reveals</a> Bitcoin's social dominance having surged to 43.06%, meaning nearly half of all crypto conversations are about BTC. While this underscores Bitcoin's lead, such high retail FOMO levels have historically preceded local tops or cooldown periods.
Trader Niels <a href="https://x.com/Web3Niels/status/1945161856999416121">summed</a> up the moment, saying, "Bitcoin is back where it belongs — at the center of the story."
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46421044/bitcoin-advocate-says-btc-will-emulate-2021-dogecoin-run-this-thesis-will-retire-your-bloodline">Bitcoin Advocate Says BTC Will Emulate 2021 Dogecoin Run: &#8216;This Thesis Will Retire Your Bloodline&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SEI

$SHIB

$SOL

$XRP

Bitcoin, XRP, Dogecoin Dip But Ethereum Outperforms After Inflation Report

At first glance, the multinational clothing and accessories retailer Gap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) may seem like a poor investment. With many consumers facing challenging economic conditions, a clear incentive exists to reduce spending on non-essentials, which is problematic for fashion-centric businesses. There's also the matter of global supply chain risks due to the <a href="https://www.benzinga.com/topic/tariffs">Trump administration's tariffs</a>. Sure enough, GAP stock has been hit badly, but that's not the entire story.
No, this isn't an exercise in irrationality. There's no question that millions of Americans are hurting, reflected in cutbacks on dining out and increased expenditures on comfort foods. Naturally, such headwinds impose downstream consequences on other sectors. Further, while clothing represents a necessity, consumers in a tough environment may not necessarily go for the highest-quality offerings (which of course tend to be pricier).
At the same time, it's also fair to point out that Gap saw comparable <a href="https://www.gapinc.com/en-us/articles/2025/05/gap-inc-reports-first-quarter-fiscal-2025-results#:~:text=First%20quarter%20net%20sales%20of,share%20gains%20for%20the%20brand.">sales</a> in the first quarter rise 3%, marking the ninth consecutive quarter of market share gains. What this fundamental catalyst translates to is that the retailer is resonating with consumers. So, while GAP stock may be swimming in red ink, the underlying nuances may not be as terrible as the market thinks.
Another point of contention working against the fashion brand is the political realm. Like many other businesses, Gap is reliant on supply chains that flow through China. With U.S.-China relations strained and President Trump's tough rhetoric not exactly smoothing matters over, GAP stock clearly carries risks. Nevertheless, the underlying company has been reducing its dependency on China and <a href="https://www.supplychaindive.com/news/gap-sourcing-strategy-inventory-Q4-richard-dickson/710143/">retooling</a> its sourcing strategy.
To be sure, these last points aren't going to make GAP stock the greatest investment ever. But from a contrarian trader's perspective, there's a legitimate justification for a bounce-back.
<h2 class="wp-block-heading">Narrowing Down a Strategy for GAP Stock</h2>
While it's possible that investors may be discounting the positives that Gap offers, it's admittedly an extraordinary claim on my part to suggest that, based on the above opinion, GAP stock is compellingly mispriced. I'm almost certainly not the first person to notice these positives, so that can't be the main reason for my bullishness. Instead, I'm relying on the quantitative argument.
Quantitative traders or quants at the core think in terms of conditional logic: What is the probability of B given that A has occurred? This statement is mathematically expressed as P(B&#x7C;A) and it's the foundation of empirical analysis of the financial markets.
As powerful as this methodology is, one of the missteps (in my opinion) is that quants tend to conduct the conditional logic on either the share price or its many derivatives (such as percentage gain or loss). However, the share price is an unbounded continuous signal, meaning that it can theoretically rise forever and that there's no way to objectively categorize it (i.e. a "good" price or a "bad" price).
Given the limitations, it's arguably better to compress the price action into the first-order principles of market breadth or sequences of accumulative and distributive sessions. This answers the root question: was the market a net buyer or net seller of the security at hand? By examining the foundation of demand, we can segregate chaotic price discovery into distinct behavioral states.
Conducting the above exercise across rolling 10-week intervals for GAP stock reveals the following demand profile:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>L10 Category</td>
<td>Sample Size</td>
<td>Up Probability</td>
<td>Baseline Probability</td>
<td>Delta</td>
<td>Median Return if Up</td>
</tr>
<tr>
<td>2-8-D</td>
<td>10</td>
<td>70.00%</td>
<td>49.56%</td>
<td>20.44%</td>
<td>1.04%</td>
</tr>
<tr>
<td>3-7-D</td>
<td>32</td>
<td>50.00%</td>
<td>49.56%</td>
<td>0.44%</td>
<td>3.26%</td>
</tr>
<tr>
<td>3-7-U</td>
<td>9</td>
<td>77.78%</td>
<td>49.56%</td>
<td>28.22%</td>
<td>2.96%</td>
</tr>
<tr>
<td>4-6-D</td>
<td>59</td>
<td>50.85%</td>
<td>49.56%</td>
<td>1.29%</td>
<td>3.41%</td>
</tr>
<tr>
<td>4-6-U</td>
<td>24</td>
<td>45.83%</td>
<td>49.56%</td>
<td>-3.73%</td>
<td>2.08%</td>
</tr>
<tr>
<td>5-5-D</td>
<td>40</td>
<td>40.00%</td>
<td>49.56%</td>
<td>-9.56%</td>
<td>2.16%</td>
</tr>
<tr>
<td>5-5-U</td>
<td>42</td>
<td>52.38%</td>
<td>49.56%</td>
<td>2.82%</td>
<td>7.50%</td>
</tr>
<tr>
<td>6-4-D</td>
<td>21</td>
<td>61.90%</td>
<td>49.56%</td>
<td>12.34%</td>
<td>3.80%</td>
</tr>
<tr>
<td>6-4-U</td>
<td>43</td>
<td>46.51%</td>
<td>49.56%</td>
<td>-3.05%</td>
<td>5.66%</td>
</tr>
<tr>
<td>7-3-D</td>
<td>2</td>
<td>50.00%</td>
<td>49.56%</td>
<td>0.44%</td>
<td>13.51%</td>
</tr>
<tr>
<td>7-3-U</td>
<td>24</td>
<td>41.67%</td>
<td>49.56%</td>
<td>-7.89%</td>
<td>2.94%</td>
</tr>
<tr>
<td>8-2-U</td>
<td>14</td>
<td>42.86%</td>
<td>49.56%</td>
<td>-6.70%</td>
<td>3.60%</td>
</tr>
<tr>
<td>9-1-U</td>
<td>1</td>
<td>0.00%</td>
<td>49.56%</td>
<td>-49.56%</td>
<td>N/A</td>
</tr>
</tbody>
</table>
</figure>
In the trailing two months, GAP stock is printing a "6-4-D" sequence: six up weeks, four down weeks, with a negative trajectory across the 10-week period. It's a relatively rare sequence, having materialized only 21 times since January 2019. Part of what makes it distinct is that the trajectory is negative despite the balance of accumulative sessions outweighing distributive.
Still, the biggest takeaway from an options trading perspective is the conditional probability. If the 6-4-D flashes, the following week's price action tends to rise 61.9% of the time. Further, the median return under this positive pathway is 3.8%.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15144821/GAP-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-986532" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15144821/GAP-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15144821/GAP-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15144821/GAP-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15144821/GAP-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
Based on the price at the time of writing, GAP stock could potentially rise to $21.45 within a week or two. Should the bulls maintain control of the market over the next four weeks, a push toward the $22 level isn't out of the question.
<h2 class="wp-block-heading">Playing the Contrarian Game the Smart Way</h2>
Armed with the market intelligence above, aggressive speculators may consider the 20/22 bull call spread expiring Aug. 15. This transaction involves buying the $20 call and simultaneously selling the $22 call, for a net debit paid of $$97 (the most that can be lost in the trade). Should GAP stock rise through the short strike price ($22) at expiration, the maximum reward is $103, a payout of just over 106%.
What makes this trade attractive is that market makers are unlikely to anticipate a rebound. As a baseline, GAP stock suffers from a negative bias. On any given week (since January 2019), the chance that a long position will be profitable is only 49.42%. Therefore, the statistical response to the 6-4-D sequence implies that the bullish trader is receiving 12.48 percentage points of favorable odds.
That said, it's important to realize that we're talking about probabilities, not certainties. GAP stock is historically risky. In addition, the market being an open system means that outside influences can easily disrupt the paradigm. Still, the above quantitative approach provides an empirical framework, thus helping crystallize the decision-making process.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46425416/jamie-dimon-admits-big-banks-are-behind-in-the-stablecoin-race">Jamie Dimon Admits Big Banks Are Behind In The Stablecoin Race</a></li>
</ul>
The opinions and views expressed in this content are those of the individual author and do not necessarily reflect the views of Benzinga. Benzinga is not responsible for the accuracy or reliability of any information provided herein. This content is for informational purposes only and should not be misconstrued as investment advice or a recommendation to buy or sell any security. Readers are asked not to rely on the opinions or information herein, and encouraged to do their own due diligence before making investing decisions.
Photo: Shutterstock

Equities

Long Ideas

Options

Options Corner: Wall Street Hates Gap Inc But It's Ignoring This Signal

<a href="https://www.bostonfed.org/news-and-events/speeches/2025/using-data-in-monetary-policymaking.aspx">https://www.bostonfed.org/news-and-events/speeches/2025/using-data-in-monetary-policymaking.aspx</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Collins Says Changes In Interest Rate Policy Play Out Over Different Horizons; Seeing Some Evidence Of A Slowdown In Labor Demand Amid Slowdown In Labor Supply Growth

Barclays analyst Lauren Lieberman maintains PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) with a Equal-Weight and lowers the price target from $135 to $132.

Barclays Maintains Equal-Weight on PepsiCo, Lowers Price Target to $132

Barclays analyst Lauren Lieberman maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Equal-Weight and raises the price target from $160 to $161.

Barclays Maintains Equal-Weight on Procter & Gamble, Raises Price Target to $161

Barclays analyst Lauren Lieberman maintains Reynolds Consumer Prods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REYN#NASDAQ">REYN</a>) with a Equal-Weight and lowers the price target from $22 to $21.

REYN

Barclays Maintains Equal-Weight on Reynolds Consumer Prods, Lowers Price Target to $21

The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) is <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46422755/the-trade-desk-extends-rally-on-sp-500-entry-news">trading higher</a> Tuesday after the digital advertising company announced that it would be added to the S&amp;P 500 Index. This is considered a bullish dynamic because it expands the number of institutional investors who can invest in the stock.
There is a chance it is about to fill a gap. This could mean a rapid move higher. It is why The Trade Desk is our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
As you can see on the chart, the shares have run into resistance around $85.50. This isn't a coincidence. On Feb. 12, the stock closed at $122.23. The next day, it opened at $85.18. Because there was no trading between these prices, it appears as a blank space or ‘gap' on the chart (see below).
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="580" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15152812/one16-1024x580.png" alt="" class="wp-image-986576" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15152812/one16-1024x580.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15152812/one16-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15152812/one16-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15152812/one16.png 1453w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
See Also:<a href="https://www.benzinga.com/markets/economic-data/25/07/46413961/june-inflation-cpi-report"> June Inflation Lands As Expected — But Cooler Core Reading Fuels Fed Rate Cut Hopes</a>
Some of the people who bought The Trade Desk shares around this opening price thought they got a bargain. The price was down by almost 33%.
However, as soon as they finished buying, the price dropped even further. When this happened, many of those who bought shares experienced buyer's remorse. Some of them decided to hold onto their losing positions.
They also decided that if they could eventually do so, they would sell their stocks at the same price they paid for them to get out at breakeven. So, when the shares rallied back to around $85 this morning, they placed sell orders.
The large number of these orders created resistance around the price. If the stock can break this resistance, there is a good chance it makes a rapid move higher. It would be entering the same price levels that it gapped down through in February, but going in the opposite direction.
One of the main reasons why resistance forms in markets is because of buyer's remorse. People try to sell things on the way back up so they can get out without losing money.
There was no trading in the price levels that their shares gapped down through. This means there won't be any remorseful sellers trying to get out on the way up.
The lack of sell interest at these levels could mean the buyers will need to be aggressive and force the price higher to acquire shares. This could create a new uptrend and the gap may be refilled.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46424889/tech-stocks-hit-new-highs-as-ai-momentum-builds-whats-moving-markets-tuesday">Tech Stocks Hit New Highs As AI Momentum Builds: What&#8217;s Moving Markets Tuesday?</a></li>
</ul>
Image: Shutterstock

Technicals

Trading Ideas

Stock Of The Day: Will The Trade Desk Fill The Gap?

Barclays analyst Lauren Lieberman maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Equal-Weight and raises the price target from $63 to $84.

Barclays Maintains Equal-Weight on Estee Lauder Cos, Raises Price Target to $84

<ul>
<li>Combined company is now named "GrabAGun Digital Holdings Inc." and is expected to trade on the NYSE under the tickers "PEW" and "PEWW"</li>
<li>GrabAGun is a fast growing, digitally native retailer of firearms and ammunition ("F&amp;A"), related accessories and other outdoor products focused on the next generation of firearms enthusiasts, sportsmen and defenders</li>
<li>Transaction proceeds successfully fund GrabAGun's balance sheet with over $179 million of gross proceeds to help accelerate growth and acquisition plans</li>
<li>Donald Trump Jr. joins GrabAGun's Board of Directors and will ring the NYSE Opening Bell alongside Colombier II and GrabAGun on July 16, 2025</li>
<li>Near-zero redemptions of Colombier II shares signals clear confidence in the GrabAGun business and broader 2A movement, compared to historical performance of other SPACs since 2022</li>
</ul>

CLBR

Donald Trump Jr. Joins GrabAGun's Board Of Directors And Will Ring The NYSE Opening Bell Alongside Colombier II And GrabAGun On July 16, 2025

Barclays analyst Andrew Lazar maintains Treehouse Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) with a Equal-Weight and lowers the price target from $25 to $21.

Barclays Maintains Equal-Weight on Treehouse Foods, Lowers Price Target to $21

Fed's Collins Says Achieving Fed's Mandates Is About Hitting Goals Over Longer Period Of Time; We Don't Know Exactly Where Maximum Employment Is; Over Longer Run, Fed Goals Are Complementary; Changes In Interest Rate Policy Play Out Over Different Horizons

&nbsp;
Combined company is now named &quot;GrabAGun Digital Holdings Inc.&quot; and is expected to trade on the NYSE under the tickers &quot;PEW&quot; and &quot;PEWW&quot;
<ul>
<li>GrabAGun is a fast growing, digitally native retailer of firearms and ammunition (&quot;F&amp;A&quot;), related accessories and other outdoor products focused on the next generation of firearms enthusiasts, sportsmen and defenders</li>
<li>Transaction proceeds successfully fund GrabAGun&#39;s balance sheet with over $179 million of gross proceeds to help accelerate growth and acquisition plans</li>
<li>Donald Trump Jr. joins GrabAGun&#39;s Board of Directors and will ring the NYSE Opening Bell alongside Colombier II and GrabAGun on July 16, 2025</li>
<li>Near-zero redemptions of Colombier II shares signals clear confidence in the GrabAGun business and broader 2A movement, compared to historical performance of other SPACs since 2022</li>
</ul>
Metroplex Trading Company LLC d.b.a. GrabAGun.com (&quot;GrabAGun&quot;), an online retailer of firearms, ammunition and related accessories, and Colombier Acquisition Corp. II (&quot;Colombier II&quot;) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLBR#NYSE">CLBR</a>), a special purpose acquisition company, today announced the completion (the &quot;Closing&quot;) of their previously announced business combination (the &quot;Business Combination&quot;), which was approved by Colombier II shareholders at an extraordinary general meeting on July 15, 2025.
Following the Closing, the go-forward public company is named GrabAGun Digital Holdings Inc. (&quot;GrabAGun Digital&quot; or the &quot;Company&quot;), and its common stock and warrants are expected to commence trading on the New York Stock Exchange (NYSE) under the ticker symbols &quot;PEW&quot; and &quot;PEWW&quot;, respectively, on July 16, 2025. As a result of this transaction, (i) the Company has received over $179 million of gross proceeds (over $119 million, after secondary proceeds and transaction and advisory expenses), which will be used to for working capital and other corporate purposes to accelerate the Company&#39;s future growth initiatives, acquisition plans and other general corporate expenses and (ii) Colombier II and GrabAGun became wholly-owned subsidiaries of GrabAGun Digital.

&nbsp;

GrabAGun Completes Business Combination With Colombier II; To Commence Trading On NYSE Under Ticker "PEW"

Press Releases

COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEP

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders

NUBURU Files $100M SEC Registration Statement to Enhance Capital Flexibility for Completion of Defense Acquisition and Blue Laser Technology Revitalization Targeting a $500B Defense Market

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

Small Cap

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

AVDX

BURU

CKPT

COEP

KRON

OPTN

PORT

PPBI

RGLS

SAGE

SWTX

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

Clene

Coeptis Therapeutics Holdings, Inc. - Common Stock

Dyadic International, Inc. - Common Stock

Dyadic International

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroGen

Generation Bio

Kala Bio

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Kezar Life Sciences

Lantern Pharma

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Nanoviricides

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

Ovid Therapeutics

PepGen

Pluri

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Rein Therapeutics

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Shattuck Labs

vTv Therapeutics Inc. - Class A Common Stock

Comments

Coeptis Therapeutics

Notizie

Ultime notizie per Coeptis Therapeutics (NASDAQ:COEP) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO